The care gap: underuse of statin therapy in the elderlyGAW, A.International journal of clinical practice (Esher). 2004, Vol 58, Num 8, pp 777-785, issn 1368-5031, 9 p.Article

Secondary prevention of coronary heart disease in practiceLINDSAY, G. M; GAW, A.Physiotherapy. 1995, Vol 81, Num 7, issn 0031-9406, p. 398Article

Characterization of commercial antibodies for use in high resolution apo(a) phenotyping by immunoblot analysisGAW, A; CHIESA, G.Clinica chimica acta. 1995, Vol 240, Num 1, pp 75-81, issn 0009-8981Article

Simvastatin during warfarin therapy in hyperlipoproteinaemiaGAW, A; WOSORNU, D.Lancet (British edition). 1992, Vol 340, Num 8825, pp 979-980, issn 0140-6736Article

Are we negating the benefits of CABG by forgetting secondary prevention?BELCHER, P. R; GAW, A; COOPER, M et al.Journal of human hypertension. 2002, Vol 16, Num 10, pp 691-697, issn 0950-9240, 7 p.Article

Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemiaCASLAKE, M. J; PACKARD, C. J; GAW, A et al.Arteriosclerosis and thrombosis. 1993, Vol 13, Num 5, pp 702-711, issn 1049-8834Article

HEALTH CARE FOR THE CHINESE COMMUNITY IN BOSTONLI F. P; SCHLIEF N. Y; CHANG C. J et al.AMER. J. PUBL. HLTH. 1972, Vol 62, Num 4, pp 536-539Article

Impact of Apo(a) length polymorphism and the control of plasma Lp(a) concentrations evidence for a threshold effectGAW, A; BROWN, E. A; FORD, I et al.Arteriosclerosis, thrombosis, and vascular biology. 1998, Vol 18, Num 12, pp 1870-1876, issn 1079-5642Article

Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemiaDEMANT, T; GAW, A; WATTS, G. F et al.Journal of lipid research. 1993, Vol 34, Num 1, pp 147-156, issn 0022-2275Article

Genetic variation in the interleukin-1β-converting enzyme associates with cognitive function. The PROSPER studyTROMPET, S; DE CRAEN, A. J. M; MACFARLANE, P. W et al.Brain. 2008, Vol 131, pp 1069-1077, issn 0006-8950, 9 p., 4Article

Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets : The Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) studyMARTINEAU, P; GAW, A; DE TERESA, E et al.Atherosclerosis. 2007, Vol 191, Num 1, pp 135-146, issn 0021-9150, 12 p.Article

The design of a prospective Study of Pravastatin in the Elderly at risk (PROSPER)SHEPHERD, J; BLAUW, G. J; LAGAAY, A. M et al.The American journal of cardiology. 1999, Vol 84, Num 10, pp 1192-1197, issn 0002-9149Article

Healthy ageing: addressing acute coronary syndrome?GAW, A.European heart journal supplements. 2001, Vol 3, Num N, pp N11-N15, issn 1520-765XConference Paper

Atherogenic lipid profile in elderly patients with ischaemic cerebrovascular diseaseCUCHEL, M; STOTT, D. J; GAW, A et al.Lancet (British edition). 2000, Vol 356, Num 9227, pp 401-402, issn 0140-6736Article

Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolismGAW, A; PACKARD, C. J; LINDSAY, G. M et al.Arteriosclerosis, thrombosis, and vascular biology. 1996, Vol 16, Num 2, pp 236-249, issn 1079-5642Article

Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidismPACKARD, C. J; SHEPHERD, J; LINDSAY, G. M et al.The Journal of clinical endocrinology and metabolism. 1993, Vol 76, Num 5, pp 1209-1216, issn 0021-972XArticle

Effect of atorvastatin on circulating hsCRP concentrations: A sub-study of the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) studyGENSINI, G. F; GORI, A. M; MARTINEAU, P et al.International journal of cardiology. 2010, Vol 142, Num 3, pp 257-264, issn 0167-5273, 8 p.Article

Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention StudyGAW, A; BROWN, E. A; DOCHERTY, G et al.Atherosclerosis. 2000, Vol 148, Num 1, pp 95-100, issn 0021-9150Article

Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsiaSATTAR, N; GAW, A; PACKARD, C. J et al.British journal of obstetrics and gynaecology (Print). 1996, Vol 103, Num 7, pp 614-620, issn 0306-5456Article

Effects of ciprofibrate on LDL metabolism in manGAW, A; PACKARD, G. J; CASLAKE, M. J et al.Atherosclerosis. 1994, Vol 108, Num 2, pp 137-148, issn 0021-9150Article

A case of meningoccal endocarditisGUNN, J; GAW, A; TRUEMAN, A. M et al.European heart journal. 1992, Vol 13, Num 7, pp 1004-1005, issn 0195-668XArticle

Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemiaSERIES, J. J; GAW, A; KILDAY, C et al.British journal of clinical pharmacology. 1990, Vol 30, Num 1, pp 49-54, issn 0306-5251Article

Testing cognitive function in elderly populations: the PROSPER studyHOUX, P. J; SHEPHERD, J; GAW, A et al.Journal of neurology, neurosurgery and psychiatry. 2002, Vol 73, Num 4, pp 385-389, issn 0022-3050Article

Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohortGAW, A; DOCHERTY, G; BROWN, E. A et al.Atherosclerosis. 1999, Vol 143, Num 2, pp 445-450, issn 0021-9150Article

Evidence based approach for the management of mixed hyperlipidaemiaGAW, A.Atherosclerosis. 1998, Vol 137, pp S97-S100, issn 0021-9150, SUPConference Paper